Anti-Tumour Necrosis Factor Therapy for Ulcerative Colitis: Evidence to Date

Author： Thukral Chandrashekhar Cheifetz Adam Peppercorn Mark A.

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.16, 2006-01, pp. : 2059-2065

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-tumour necrosis factor therapy in seronegative spondyloarthritis

By Swales Catherine Bowness Paul

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 219-222

Royal College Of Physicians

Access to resources Recommend Favorite

Structure-Modifying Capacity of Anti-Tumour Necrosis Factor- Therapy in Ankylosing Spondylitis

By Filip De Keyser Baeten Dominique Filip Van den Bosch Kruithof Elli Verbruggen Gust Mielants Herman Veys Eric

Drugs, Vol. 64, Iss. 24, 2004-01 ,pp. : 2793-2811

Adis International

Access to resources Recommend Favorite

Anti-Tumour Necrosis Factor-α Therapy for Rheumatoid and Other Inflammatory Arthropathies: Update on Safety in Older Patients

By Ornetti Paul Chevillotte Hélène Zerrak Amal Jean Francis Maillefert

Drugs & Aging, Vol. 23, Iss. 11, 2006-01 ,pp. : 855-860

Adis International

Access to resources Recommend Favorite

The Future Role of Anti-Tumour Necrosis Factor- Products in the Treatment of Crohn's Disease

By van Hogezand R.A. Verspaget H.W.

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 299-305

Adis International

Access to resources Recommend Favorite

Tumor Necrosis Factor Alpha in Ulcerative Colitis and Diverticular Disease Associated Colitis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 187-194

Bentham Science Publishers

Access to resources Recommend Favorite